Biotech & MedTech
-
Jack Lifton with StageZero’s James Howard-Tripp on the advantages of non-invasive cancer diagnostic testing
In a recent InvestorIntel interview, Jack Lifton speaks with James Howard-Tripp, Chairman and CEO of StageZero Life Sciences…
-
Cloud DX brings Star Trek technology to today
One of the latest publicly listed digital healthcare companies began trading on the TSX Venture on April 15,…
-
eResearch’s Chris Thompson with James Howard-Tripp on StageZero’s COVID-19 testing revenue
In a recent InvestorIntel interview, Chris Thompson speaks with James Howard-Tripp, Chairman and CEO of StageZero Life Sciences…
-
James Howard-Tripp on StageZero’s Q1 Results, Aristotle as part of the AVRT Program and the Rexall Partnership for COVID-19 Saliva Tests
In a recent InvestorIntel interview, Tracy Weslosky spoke with James Howard-Tripp, Chairman and CEO of StageZero Life Sciences Ltd. (TSX:…
-
Steve Saviuk on Valeo Pharma’s Redesca, an injectable anticoagulant drug that just commenced shipment in Canada
In a recent InvestorIntel interview, Tracy Weslosky spoke with Steve Saviuk, CEO of Valeo Pharma Inc. (CSE: VPH…
-
Hugh Rogers on the European approval of the XPhyto Therapeutics point-of-care SARS-CoV-2 (COVID-19) RT-PCR test system
In a recent InvestorIntel interview, Peter Clausi spoke with Hugh Rogers, CEO and Director of XPhyto Therapeutics Corp. (CSE:…
-
Sixth Wave Innovations Dr Jon Gluckman on the colorimetric detection of SARS-CoV-2
In a recent InvestorIntel interview, Tracy Weslosky spoke with Dr. Jon Gluckman, President, CEO and Founder of Sixth…
-
StageZero’s New Cancer-Testing Platform and Health Clinics Acquisition Forms Telemedicine “Circle of Care”
StageZero Life Sciences Ltd. (TSX: SZLS) is a life science and telehealth company that recently launched Aristotle®, which…
-
Valeo Pharma launches Redesca™ and is forecasting company revenues to increase 20x by 2025
Bringing new pharmaceutical products to market is a long and expensive process. One Canadian company has found an…